Loading companies…
Loading companies…
Israel · Healthtech · Hardware
Develops a minimally invasive implantable device to treat benign prostatic hyperplasia in men
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series C | $21M | European Innovation Council (EIC) — Role not disclosedJunson Capital — Role not disclosedMedVenture — Role not disclosedNew Rhein Healthcare Investors — Role not disclosed |